News Archive

Strengthening supply chain cyber security at the MHRA

27th February 2026

The MHRA has published its new approach to bolstering cyber security across its supply chains to better protect regulated products and services.

Read More+

EMA Human Medicines Highlights – February 2026

26th February 2026

The European Medicines Agency’s Human Medicines Highlights newsletter provides key regulatory updates for medicines in the EU.

Read More+

Regulation as an enabler of innovation — a regional perspective

26th February 2026

The MHRA shares insights on how regulatory frameworks can drive innovation and economic growth across UK regions.

Read More+

Get integrated scientific advice from the MHRA and NICE for medicines

23rd February 2026

The MHRA and NICE now offer a joined-up scientific advice service to help medicine developers align regulatory and health technology assessment evidence needs early in development.

Read More+

UK medical device testing hits record high as MHRA backs growth in brain and AI technology

19th February 2026

UK medical device testing hits record high as MHRA backs growth in brain and AI technology

Read More+

Concept paper on revision of the guidelines on good manufacturing practice for medicinal products - annex 6 manufacture of medicinal gases

18th February 2026

Consultation open: 11/02/2026 to 11/04/2026

Read More+

Concept paper on the revision of the guidelines on Good Manufacturing Practice for medicinal products - Annex 15 - Qualification and validation

18th February 2026

Consultation dates: 09/02/2026 to 09/04/2026

Read More+

EMA CVMP Meeting Highlights — 10–12 February 2026

18th February 2026

he European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) published outcomes from its February 2026 plenary meeting, covering new product opinions, variations, pharmacovigilance updates and draft guidance.

Read More+

EMA PRAC Meeting Highlights — 9–12 February 2026

18th February 2026

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) concluded a major safety review and issued key risk-management recommendations for human medicines.

Read More+

Global commitment on display as countries negotiate key annex to the Pandemic Agreement

18th February 2026

WHO Member States have shown strong unity in advancing negotiations on a critical annex to the global Pandemic Agreement aimed at improving pandemic preparedness and equity.

Read More+